Δευτέρα 11 Νοεμβρίου 2019


Re-Introducing Nuts in Allergic Patients
Condition:   Tree Nut Allergy Interventions:   Other: Procedure A;   Other: Procedure B;   Other: Control group Sponsors:   National and Kapodistrian University of Athens;   Hellenic Society of Allergology and Clinical Immunology Recruiting (Source: ClinicalTrials.gov)
MedWorm Allergy & Immunology Clinical Trials
Tue Nov 05, 2019 18:00
Transmission of Tuberculosis Among Illicit Drug Use Linkages
Conditions:   Tuberculosis;   Illicit Drug Use Intervention:   Behavioral: Smoked illicit drug use Sponsors:   Boston Medical Center;   University of Stellenbosch;   Desmond Tutu HIV Foundation/ University of Cape Town;   Boston University;   Medical Research Council, South Africa;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Allergy & Immunology Clinical Trials
Tue Nov 05, 2019 18:00
Right middle cerebral artery infarct after minor head trauma in an infant: case report and literature review - Khalid MT, Chan DWS, Tan EEK, Seow WT, Ng LP, Low DCY, Low SYY.
Ishaemic stroke (IS) in the paediatric population is extremely rare. In this age group, the occurrence of IS often concurs with underlying congenital heart disease, haematological, metabolic or immunological conditions. In contrast, the association between... (Source: SafetyLit)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Allergy & Immunology Top 20
Mon Nov 11, 2019 09:38
Input –Output Functions in Human Heads Obtained With Cochlear Implant and Transcranial Electric Stimulation
ConclusionThese results provide a novel objective measure of electric stimulation in the human head, which can help to optimize stimulation parameters that improve neural excitation of deep structures by reducing the influence of current spread. (Source: Neuromodulation: Technology at the Neural Interface)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Audiology Research
Mon Nov 11, 2019 00:00
What is palliative care, and who can benefit from it?
The American population is getting older and sicker. More Americans are facing life-threatening illness when approaching end of life. Palliative care has grown to meet the complex needs of this population. And yet, according to a 2017 article in the journal Palliative Care, many people living with a chronic life-threatening illness either do not receive any palliative care, or receive services only in the last phase of their illness. The National Consensus Project Clinical Practice Guidelines for...
MedWorm Cancer & Oncology Blogs
Mon Nov 11, 2019 16:30
Performance tracker 2019: a data-driven analysis of the performance of public services
Institute for Government - Jointly published with the Chartered Institute of Public Finance and Accountancy (CIPFA), this report projects the demand and spending on nine public services for the next five years: GPs, hospitals, adult social care, children ’s social care, neighbourhood services, police, prisons, courts, and schools. The report estimates that the government and local authorities will spend £191.1 billion on these nine services by 2023/24. While this may be enough to meet demand (except...
MedWorm Cancer & Oncology Blogs
Mon Nov 11, 2019 00:00
What ’s the X-factor in life or death medical situations?
I was a brand-new intern in the intensive care unit, and Cassandra was the very first patient I saw there. A petite, slender woman, she was rolled in on a stretcher, accompanied by her tall, athletic husband, Jack. Cassandra was in her 20s, like me — but mortally ill. That grabbed my attention from the […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more. (Source: Kevin, M.D. - Medical Weblog)MedWorm Message: Have you tried our new medical...
MedWorm Cancer & Oncology Blogs
Mon Nov 11, 2019 19:00
Including the patient perspective on tumor boards
I am a firm believer that medicine is best practiced as a team, with the one undergoing treatment at the center participating fully. It ’s a belief embedded in the multidisciplinary care model. I have been fortunate to have been exposed to multidisciplinary clinics in my fellowship at Memorial Sloan Kettering Cancer Center and have worked […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more. (Source: Kevin, M.D. - Medical Weblog)
MedWorm Cancer & Oncology Blogs
Mon Nov 11, 2019 01:00
AVEO Oncology and Biodesix Announce Initiation of the CyFi-2 Study, a Phase 2 Randomized Study of Ficlatuzumab in Combination with High-Dose Cytarabine vs. High-Dose Cytarabine Alone in Patients with Relapsed and Refractory AML
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- November 8, 2019 -- AVEO Oncology (AVEO) and Biodesix, Inc. today announced the initiation of the CyFi-2 study, a randomized Phase 2 clinical study evaluating ficlatuzumab, AVEO’s potent hepatocyte... (Source: Drugs.com - Clinical Trials)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Clinical Trials
Mon Nov 11, 2019 20:11
Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer
Condition:   Endometrial Cancer Intervention:   Drug: anlotinib and anti PD-1 antibody Sponsor:   Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
Real World Study of Pyrotinib in Human Epidermal Growth Factor Receptor-2 (HER2) Positive Breast Cancer
Condition:   HER2-positive Breast Cancer Intervention:   Other: non-interventional Sponsor:   Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
A Study of ZN-c3 in Participants With Solid Tumors
Conditions:   Solid Tumor;   Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer;   Triple Negative Breast Cancer;   Small Cell Lung Cancer;   Metastatic Breast Cancer;   Malignant Melanoma;   Non Small Cell Lung Cancer;   Urothelial Carcinoma Interventions:   Drug: ZN-c3;   Drug: Talazoparib;   Drug: Pembrolizumab Sponsors:   K-Group Beta;   IQVIA Biotech Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful...
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma
Conditions:   Grade 3b Follicular Lymphoma;   Recurrent Diffuse Large B-Cell Lymphoma;   Recurrent Follicular Lymphoma;   Refractory Diffuse Large B-Cell Lymphoma;   Non-Hodgkin's Lymphoma Interventions:   Drug: Copanlisib;   Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Dexamethasone;   Biological: Rituximab;   Biological: Pegfilgrastim Sponsors:   University of Washington;   National Cancer Institute (NCI);   Bayer Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
Acupuncture for Breast Cancer Related Lymphedema
Condition:   Breast Cancer Lymphedema Interventions:   Other: acupuncture;   Other: sham acupuncture Sponsors:   Tianjin University of Traditional Chinese Medicine;   Baokang Hospital Affiliated to Tianjin University of Traditional Chinese Medicine;   Tianjin Medical University Cancer Institute and Hospital;   Gansu Provincial Cancer Hospital;   The Second Affiliated Hospital of Baotou Medical Colle ge Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC)
Condition:   Prostatic Cancer, Castration-Resistant Interventions:   Drug: Darolutamide(Nubeqa, BAY1841788);   Drug: Enzalutamide Sponsor:   Bayer Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
A Study of Toripalimab or Placebo Plus Chemotherapy as Treatment in Early Stage NSCLC
Condition:   Stage IIIA Non-small Cell Lung Cancer Interventions:   Drug: Toripalimab + platinum-based doublet chemotherapy;   Drug: Placebo + platinum-based doublet chemotherapy Sponsor:   Shanghai Junshi Bioscience Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma
Conditions:   Pleural Biphasic Mesothelioma;   Pleural Epithelioid Mesothelioma;   Stage I Pleural Malignant Mesothelioma AJCC v8;   Stage IA Pleural Malignant Mesothelioma AJCC v8;   Stage IB Pleural Malignant Mesothelioma AJCC v8;   Stage II Pleural Malignant Mesothelioma AJC C v8;   Stage IIIA Pleural Malignant Mesothelioma AJCC v8 Interventions:   Drug: Carboplatin;   Drug: Cisplatin;   Procedure: Decortication;   Radiation: Intensity-Modulated Radiation Therapy;   Drug: Pemetrexed;   Drug: Pemetrexed Disodium;...
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer
Conditions:   Colorectal Cancer;   Appendiceal Cancer;   Peritoneal Carcinoma Interventions:   Drug: Oxaliplatin;   Drug: mFOLFIRI Sponsor:   University of Utah Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma
Conditions:   Pancreatic Adenocarcinoma;   Pancreatic Cancer Intervention:   Biological: Autologous DC vaccine Sponsors:   Baylor College of Medicine;   Cancer Cures for Kids Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
Artificial Intelligence in Mammography-Based Breast Cancer Screening
Condition:   Breast Cancer Intervention:   Other: mammography Sponsors:   Chinese University of Hong Kong;   IBM China/Hong Kong Limited Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
De-escalation Protocols in Locoregionally Advanced Nasopharyngeal Carcinoma
Condition:   Nasopharyngeal Carcinoma Interventions:   Radiation: Toxicities reduced treatment;   Radiation: Conventional treatment Sponsor:   Chaosu Hu Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer
Condition:   Cancer Metastatic Interventions:   Drug: Paclitaxel injection;   Drug: Capecitabine tablets;   Drug: Letrozole 2.5mg;   Drug: Anastrozole 1mg;   Drug: Fulvestrant Prefilled Syringe;   Drug: Abemaciclib Sponsor:   UNICANCER Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Abiraterone Acetate
Condition:   Metastatic Castration-resistant Prostate Cancer Intervention:   Drug: 18F-fluciclovine PET Scan Sponsors:   Tulane University;   Blue Earth Diagnostics Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
Applying PET/MR in Oncology - a Prospective Project
Conditions:   Lymphoma;   Nasopharyngeal Cancer;   Esophageal Cancer;   Cervical Cancer;   Hepatobiliary Cancer;   Pancreatic Cancer;   Sarcoma;   Prostate Cancer Intervention:   Diagnostic Test: PET/MR scan Sponsor:   Tel-Aviv Sourasky Medical Center Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America
Condition:   Breast Cancer Interventions:   Drug: Bevacizumab;   Drug: Trastuzumab;   Drug: Ado-trastuzumab emtamsine;   Drug: Pertuzumab;   Drug: Atezolizumab;   Drug: Capecitabine Sponsors:   Hoffmann-La Roche;   Latin American Cooperative Oncology Group Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC
Condition:   Hepatocellular Carcinoma Interventions:   Drug: Anlotinib;   Device: TACE+RFA Sponsor:   Jinglong Chen Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
Sentinel Lymph Node Biopsy in Early Breast Cancer: a Real-world Multicenter Cross-sectional Study (CABS001 Study)
Conditions:   Breast Cancer;   Sentinel Lymph Node Interventions:   Diagnostic Test: mapping agent;   Procedure: neoadjuvant chemotherapy Sponsor:   Xijing Hospital Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis
Conditions:   Colorectal Cancer Stage IV;   Colorectal Cancer Metastatic;   Colorectal Cancer, Genetics of;   Appendix Cancer Intervention:   Diagnostic Test: prospective single arm biomarker (plasma cell-free DNA hydroxymethylation) study Sponsor:   University of Chicago Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
A Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics Study
Conditions:   Solid Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Prostatic Neoplasms Intervention:   Drug: TAK-573 Sponsor:   Millennium Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00

Evaluation of the Length of Treatment With PD-1/PD-L1 Inhibitors in Patients With Advanced Solid Tumors
Conditions:   Advanced Solid Tumors;   NSCLC;   Bladder Cancer;   HNSCC;   Renal Cancer;   Melanoma;   Anal Cancer;   Colorectal Cancer;   Cholangiocarcinoma;   Gastric Cancer;   Hepatocellular Carcinoma Interventions:   Drug: Continue PD-1/PD-L1 Inhibitors treatment;   Other: Discontinue PD-1/PD-L1-1 inhibitor Sponsor:   Antoinette J Wozniak Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for...
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma
Condition:   Glioblastoma Interventions:   Drug: Anlotinib Hydrochloride;   Radiation: Radiation therapy;   Drug: Temozolomide Sponsors:   People's Hospital of Guangxi;   First Affiliated Hospital of Guangxi Medical University;   Cancer Hospital of Guangxi Medical University;   Liuzhou Worker's Hospital;   Nanxishan Hospital;   Liuzhou People's Hospital;   Affiliated Hospital of Guilin University Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Nov 08, 2019 18:00
Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions:   Lymphoid Leukemia;   Non-Hodgkin's Lymphoma;   Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma Interventions:   Drug: Copanlisib;   Drug: Copanlisib Hydrochloride;   Biological: Rituximab;   Drug: Bendamustine;   Drug: Bendamustine Hydrochloride Sponsors:   University of Washington;   National Cancer Institute (NCI);   Bayer Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Thu Nov 07, 2019 18:00
Prehab for Cancer Surgery
Conditions:   Surgical Oncology;   Preoperative Care Intervention:   Behavioral: Exercise, nutritional optimization, and psychoeducation Sponsors:   University of Toronto;   University Health Network, Toronto;   MSH-UHN AMO Innovation Fund Recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
MedWorm Cancer & Oncology Clinical Trials
Thu Nov 07, 2019 18:00
Talk Evidence - aggravating acronyms, a time to prescribe, and screening (again)
Talk Evidence is back, with your monthly take on the world of EBM with Duncan Jarvies and GPs Carl Heneghan (also director for the Centre of Evidence Based Medicine at the University of Oxford) and Helen Macdonald (also The BMJ's UK research Editor). This month Helen talks about the messy business of colon cancer screening - which modality is... (Source: The BMJ Podcast)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account....
MedWorm Cancer & Oncology Podcasts
Mon Nov 11, 2019 12:51
Evidence-based medicine, Archibald Cochrane and tonsillectomy
Publication date: Available online 10 November 2019Source: European Annals of Otorhinolaryngology, Head and Neck DiseasesAuthor(s): O. Laccourreye (Source: European Annals of Otorhinolaryngology, Head and Neck Diseases)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm ENT & OMF Research
Mon Nov 11, 2019 19:42

Risk factors of pharyngocutaneous fistula after total laryngectomy: a systematic review and meta-analysis
ConclusionsIn our study, age, smoking, COPD, CAD, T-stage, previous radiotherapy, preoperative albumin, preoperative hemoglobin, tumor site, and treatment method were risk factors of PCF. (Source: European Archives of Oto-Rhino-Laryngology)
MedWorm ENT & OMF Research
Mon Nov 11, 2019 00:00
Reconstruction of an idiopathic hemipalatal hypoplasia: report of a case
We present a case in a 5-year-old boy, and introduce the one-stage surgical technique that we used to resolve it. (Source: The British Journal of Oral and Maxillofacial Surgery)
MedWorm ENT & OMF Research
Mon Nov 11, 2019 00:00
Prevalence and characterizaton of otomycosis among patients attending Ear, Nose and Throat clinics at Abia State University Teaching Hospital, Aba, South Eastern Nigeria
Conference abstracts (Source: The Aspergillus Website - updates)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm ENT & OMF Top 20
Sun Nov 10, 2019 23:47
How race plays a role in palliative care
“Black life remains unexpected.” I have been mulling over these words written by Ibram X. Kendi, in The Atlantic. This followed his piece exploring the “anniversary” of slavery in 2019. He experiences this 400-year marker both with hope and concern given the persistence of a split America: “ Black death matters to racist America. Black life […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more. (Source: Kevin, M.D. - Medical Weblog)
MedWorm Palliative Care Blogs
Sun Nov 10, 2019 17:00
The exploration of the knowledge, attitudes and practice behaviors of advanced care planning and its related predictors among Taiwanese nurses
Despite the documented and well known patient benefits of ACP, the completion of ACP, only a minority of patients, during the advanced or EOL stage of their illnesses, receive such care. The misconceptions abo... (Source: BMC Palliative Care)
MedWorm Palliative Care Research
Mon Nov 11, 2019 01:00
Nonimmune Hydrops Fetalis
Nonimmune hydrops fetalis (NIHF) historically has been considered a lethal fetal condition. Understanding NIHF to be a symptom or an end-stage status of a variety of fetal conditions, along with improved fetal diagnostics and interventions, has changed the landscape for at least some fetuses. Understanding the pathophysiologic mechanisms has led to the development of diagnostic algorithms, improved understanding of cause, and therefore fetal or neonatal treatments. Multidisciplinary counseling and...
MedWorm Palliative Care Research
Mon Nov 11, 2019 00:00
Evaluation of a Palliative Care Program for Nursing Homes in 7 Countries
This cluster-randomized clinical trial examines the effect of implementing the Palliative Care for Older People Steps to Success Program in 78 nursing homes in 7 countries with residents and staff outcomes at resident end of life. (Source: JAMA Internal Medicine)
MedWorm Palliative Care Research
Mon Nov 11, 2019 01:00
Palliative Care in the Nursing Home —Shifting Paradigms
When asked about their preferred location of death, most people say they would like to die at home. Few people say they would like to die in the hospital. Nobody ever says they want to die in a nursing home (NH). But the reality is that many people will live out their final days and take their last breaths in the NH setting. In 2009, more than 1 in 4 decedents in the United States died in an NH. This number is only expected to grow with population aging. (Source: JAMA Internal Medicine)
MedWorm Palliative Care Research
Mon Nov 11, 2019 01:00
Features of U.S. Primary Care Physicians and Their Practices Associated with Advance Care Planning Conversations.
CONCLUSIONS: In this sample of US primary care physicians, the types of patients seen, practice location, and physician compensation influenced whether physicians routinely discuss ACP with patients who are older and sicker. Practices demonstrating more features of APCP/PCMH models of primary care are also associated with ACP discussions. PMID: 31704752 [PubMed - in process] (Source: American Family Physician)
MedWorm Palliative Care Research
Fri Nov 01, 2019 00:00
Characteristics and course of patients with advanced hematologic malignancies receiving specialized inpatient palliative care at a German university hospital
(Source: Annals of Hematology)
MedWorm Palliative Care Research
Fri Nov 01, 2019 00:00
Barriers to palliative and hospice care utilization in older adults with cancer: A systematic review
The objective of this systematic review was to synthesize the evidence on the barriers to palliative and hospice care utilization in older adults with cancer. A systematic literature search was conducted using PubMed, CINAHL, PsycINFO, Embase, and Cochrane Library databases (from inception to 2018) in accordance to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Research articles that examined palliative or hospice care utilization in older adults with...
MedWorm Palliative Care Research
Mon Nov 11, 2019 04:07
Voice and Communication Support for Youth Who Are Transgender: Are You Ready?
As more of our students choose to live out their authentic gender expression, school-based speech-language pathologists can play a role in supporting and serving them. Some SLPs they already work with students on their caseload to align their voice and communication with their gender identity and expression. Giving Voice to Teachers on World Voice Day—or Any Day Holistic Voice Therapy for the Whole Person Can Students Qualify for Voice Treatment? For others, learning how to provide appropriate...
MedWorm Speech Therapy Blogs
Mon Nov 11, 2019 22:00
Possibilities of building peace through classroom discourse: A positive discourse analysis
Publication date: December 2019Source: Linguistics and Education, Volume 54Author(s): Luzkarime Calle-DíazAbstractColombia is a country with a history of violence. The educational context has been no exception. Examining the way peace and violence are enacted or reproduced through discourse in school settings can help to inform processes of positive social transformation. In this paper, I present a critical microethnographic study on the potential of classroom discourse for peacebuilding in a fifth...
MedWorm Speech Therapy Research
00:14
Combined restorative and compensatory treatment for primary progressive aphasia: a case report
. (Source: Aphasiology)
MedWorm Speech Therapy Research
Sun Nov 10, 2019 00:00
IJERPH, Vol. 16, Pages 4401: Tooth Malformations, DMFT Index, Speech Impairment and Oral Habits in Patients with Fetal Alcohol Syndrome
Conclusions: Children with fetal alcohol syndrome have a higher need for early developmental promotion such as speech treatment, ergotherapy, and physiotherapy. Mouthbreathing, habits, and lack of breastfeeding may result in orthodontic treatment needs. High DMFT and modified DDE indexes hint at a higher treatment and prevention need in dentistry. (Source: International Journal of Environmental Research and Public Health)
MedWorm Speech Therapy Research
Mon Nov 11, 2019 00:00
Harmonic Beamformers for Speech Enhancement and Dereverberation in the Time Domain
Publication date: Available online 9 November 2019Source: Speech CommunicationAuthor(s): J.R. Jensen, S. Karimian-Azari, M.G. Christensen, J. BenestyAbstractThis paper presents a framework for parametric broadband beamforming that exploits the frequency-domain sparsity of voiced speech to achieve more noise reduction than traditional nonparametric broadband beamforming without introducing additional distortion. In this framework, the harmonic model is used to parametrize the signal of interest by...
MedWorm Speech Therapy Research
Sun Nov 10, 2019 20:05
Short Takes
President Trump has announced his intention to nominate cancer specialist Dr. Stephen Hahn to be the next Commissioner of the Food and Drug Administration (FDA). Dr. Hahn currently serves as the Chief Medical Officer at MD Anderson Cancer Center in Texas, where he oversees clinical care. He previously worked at the National Cancer Institute and the University of Pennsylvania medical school, where he chaired the radiation oncology department for nine years. Until Dr. Hahn is confirmed by the Senate,...
MedWorm: Cancer & Oncology
01:38
South Africa: Professor Lynette Denny to receive IACR Medal of Honour
[UCT] Professor Lynette Denny, Head of the Department of Obstetrics and Gynaecology and head of the   South African Medical Research Council's Gynaecological Cancer Research Centre, is set to receive the prestigious International Agency for Research on Cancer (IARC) Medal of Honour. (Source: AllAfrica News: Health and Medicine)
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 11:54
South Africa: Gold Medal for Leading Cervical Cancer Researcher
[UCT] Cape Town -University of Cape Town (UCT) Professor Lynette Denny's 25-year body of research on cervical cancer, which affects 80% of black women in South Africa, has won a prestigious South African Medical Research Council (SAMRC) Gold Medal in its golden jubilee year. (Source: AllAfrica News: Health and Medicine)
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 11:53

EPA Leaving Libby Asbestos Superfund Site to Montana
The U.S. Environmental Protection Agency is leaving the Libby Asbestos Superfund site, but that doesn’t mean the job is finished. It’s just changing hands. The Montana Department of Environmental Quality will assume the oversight role of the Superfund site, which was part of the longest-running, man-made environmental disaster in American history. The EPA spent almost two decades decontaminating Libby and nearby Troy, Montana, a massive project stemming from the vermiculite mine operation that...
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 16:26
Pioneering new ‘ smart needle ’ could revolutionise cancer diagnosis
Scientists have developed a pioneering new technique that can detect and diagnose one of the most common types of cancer within seconds - using light. (Source: University of Bristol news)
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 11:00
Metaphor 'menu' for cancer patients launched by researchers
(Lancaster University) The first manual of expressions describing cancer has been developed by researchers to help patients make sense of their disease. The metaphor 'Menu', which will be available online from today (November 11), follows research by Lancaster University based on the views of more than 100 people involved in cancer care and analysis of more than one million words. (Source: EurekAlert! - Medicine and Health)MedWorm Message: Have you tried our new medical search engine? More powerful...
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 06:00
NIH RO1 grant to help improve ultrasound tomography for breast cancer detection
(University of Illinois College of Engineering) In the growing need to improve imaging techniques, the United States Department of Health and Human Services has awarded an RO1 grant titled 'Advanced image reconstruction for accurate and high-resolution breast ultrasound tomography' to teams at the University of Illinois at Urbana-Champaign and Wayne State University. (Source: EurekAlert! - Medicine and Health)
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 06:00
Boost for hospital workforce
70 extra frontline medical trainees created Related items fromOnMedica NHS performance figures show ‘the writing is on the wall’ Unrelenting NHS pressure affecting cancer care, say GPs and nurses NHS pressures could cause staff ‘burnout’ Also in the press Female doctors earning less than male equivalents (Source: OnMedica Latest News)
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 00:00
Diabetes prescribing costs rise 79% over past decade
Cost rises from £599m to £1.07bn since 2009 Related items fromOnMedica NHS saves £324m by switching to cheaper medicines NICE rejects breast cancer drug for NHS funding Green light for primary progressive MS drug Health-focused line on drugs misuse would save lives and money Pharmacists in primary care save time and money (Source: OnMedica Latest News)
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 00:00
Patients with chronic conditions still neglected on mental health
Quarter of areas do not have integrated mental and physical services Related items fromOnMedica Experts urge radical action on mental health crises Higher cancer risk from chronic diseases Regular not excessive exercise link to better mental health Wearable tech approach to diabetes prevention to expand Weight loss targets exceeded on NHS type 2 diabetes prevention programme (Source: OnMedica Latest News)
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 00:00
Self-Testing for Cervical Cancer Increases Screening Rates
Mailing self-sampling kits to test for the cervical cancer-causing virus HPV significantly increased screening rates for the cancer, according to a new study. (Source: WebMD Health)
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 19:52
Heart failure hospital admissions in England rise by a third in five years
Admissions have reached record levels in England, rising from 65,025 in 2013/14 to 86,474 in 2018/19, reflecting increasing numbers of people living with heart failure in UK (~920,000 people), which is placing greater burden on health service than 4 most common cancers combined. (Source: Current Awareness Service for Health (CASH))MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained...
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 16:15
Shifting the Focus of Breast Cancer to Prevention
If protective measures were widely adopted, they could significantly reduce women ’s chances of ever getting breast cancer. (Source: NYT Health)
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 14:08
Prostate cancer symptoms: Experiencing pain here could signal the deadly disease
PROSTATE cancer is the most common cancer in men in the UK and it usually develops slowly, so there may be no signs for many years. Advanced prostate cancer means the cancer has spread to other parts of the body, and experiencing pain in different areas of the body may signal the cancer has spread. (Source: Daily Express - Health)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 11:42
Clinically-led Review of NHS Access Standards
This report sets out progress so far on how each of the proposed new standards in mental health services, cancer care, elective care and urgent and emergency care is being tested and the early learning from this testing. (Source: Current Awareness Service for Health (CASH))
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 11:23
Triple negative breast cancer patients are given new hope
Kay Kingham (left), 52, from North-East London, was diagnosed with triple negative breast cancer in 2018. Three months after enrolling on a clinical trial of pembrolizumab, she had little trace of the disease. (Source: the Mail online | Health)
MedWorm: Cancer & Oncology
Sat Nov 09, 2019 23:17
Single-agent Atezolizumab Improves Survival in PD-L1-High NSCLC
Atezolizumab monotherapy improved overall survival compared with platinum-based chemotherapy as a first-line treatment in patients with wild-type non –small cell lung cancer with PD-L1 expression ≥50%. (Source: CancerNetwork)
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 18:15
When's the Right Time to Mention the'C' Word? When's the Right Time to Mention the'C' Word?
In the era of genomics and precision medicine, patients deserve a definitive diagnosis before the mention of cancer, argues oncologist Don Dizon.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 18:03
Karmanos Cancer Institute recognized its 2019 Heroes of Cancer
(Source: Karmanos Cancer Institute)
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 14:45
Lasting tumor regression of leukemia and lymphoma in mouse models achieved by U-M compound
(Michigan Medicine - University of Michigan) For decades, a transcription factor known as STAT3 has been a major therapeutic target in the treatment of cancer, but it has largely been considered 'undruggable' due to the difficulty of developing compounds to effectively inhibit its activity. Researchers at the University of Michigan Rogel Cancer Center have taken a promising new approach to targeting STAT3 -- one that was able to achieve a long-lasting and nearly complete elimination of tumors in...
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 06:00
FDA Grants Priority Review to Opdivo-Yervoy Combo in Advanced HCC
The FDA has accepted the supplemental biologics license application and granted breakthrough therapy designation to nivolumab plus ipilimumab for the treatment of patients with advanced hepatocellular carcinoma previously treated with sorafenib. (Source: CancerNetwork)
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 06:00
First HER2/4-1BB Bispecific Molecule Shows Clinical Activity in HER2+ Cancers
PRS-343, a HER2/4-1BB targeting bispecific construct, is well-tolerated and demonstrated anti-tumor activity in heavily pre-treated patient population across multiple tumor types. (Source: CancerNetwork)
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 06:00
UC research finds potential target for tumor-causing condition
(University of Cincinnati) University of Cincinnati researchers have found additional ways to target the molecular processes involved in activating a certain protein complex to potentially develop new therapies for a tumor-causing disorder. (Source: EurekAlert! - Cancer)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 06:00

Kenya: Cancer Cases Rise as Hospitals Struggle to Cope
[Nation] The prevalence of cancer is increasing worldwide. The International Agency for Research on Cancer, a WHO agency, reported 14.1 million new cancer cases, 8.2 million deaths resulting from cancer, and 32.6 million people living with cancer around the globe. (Source: AllAfrica News: Health and Medicine)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 09:48
South Africa: Demon Disease, Worse Than HIV - Soweto Women's Views On Breast Cancer
[The Conversation Africa] Low-income communities in South Africa have the lowest incidence of breast cancer in the country. But they also have the worst health outcomes. Black South African women are the least likely segment of the population to have breast cancer but the most likely to die from it. (Source: AllAfrica News: Health and Medicine)
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 08:34
DOSIsoft gets FDA nod for MU2net software
Radiation oncology and nuclear medicine software developer DOSIsoft has received...Read more on AuntMinnie.comRelated Reading: Butterfly Network launches new software for portable US Elekta, DOSIsoft sign distribution agreement DOSIsoft wins FDA nod for Planet Onco Dose software Densitas launches mammo quality assessment software DOSIsoft gets FDA OK for ThinkQA-EPIbeam, updates Planet Dose (Source: AuntMinnie.com Headlines)MedWorm Message: If you are looking to buy something in the January...
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 08:00
The Affordable Care Act's impact on insurance coverage & treatment in patients with HIV and cancer
(Wiley) A recent Cancer study reveals that, for people living with both HIV and cancer (PLWHC), implementation of the Patient Protection and Affordable Care Act (ACA) improved insurance coverage, both in states that expanded Medicaid coverage and those that did not. (Source: EurekAlert! - Medicine and Health)
MedWorm: Cancer & Oncology
Mon Nov 11, 2019 06:00
Families will be thrown a lifeline by early-years plans
Commenting on Labour Party proposals to expand free childcare and open 1,000 new Sure Start centres, UNISON general secretary Dave Prentis said: “Accessible, quality childcare and early years support can have a life-changing impact on children and their families. “Restoring the network of Sure Start centres will offer a lifeline by providing education and health services to those families most in need, after years of cuts left them in tatters. “These proposals, along with an increase in free childcare, would bring...
MedWorm: Food Science
Mon Nov 11, 2019 12:34
Police staff agree two-year pay deal in Scotland
Police staff members in Scotland have voted ‘yes’ to a two-year pay deal, which includes a 3.5% rise for 2019-20, backdated to 1 April, for most staff. Next April, wages will rise by 3%. In both years, Police Scotland staff who earn more than £80,000 a year will see a flat-rate increase of £1,600. Both years will also see a matching percentage increase on enhanced shift rates. The deal runs to the end of March 2021 and was agreed by members in an online ballot that saw a 96.7% vote in favour on...
MedWorm: Food Science
Mon Nov 11, 2019 10:44
Drugs That Worsen Heart Failure Common in Hospitalized HF Drugs That Worsen Heart Failure Common in Hospitalized HF
Commonly prescribed medications that exacerbate heart failure are often continued after — or even started during — HF hospitalization, new research suggests.Medscape Medical News (Source: Medscape Critical Care Headlines)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm: Intensive Care
00:13
'We call it the intensive care unit for a reason': SickKids ICU simulation pushes fundraising boundaries
Innovative SickKids awareness-raising event with Airbnb lets people book a room in a mock ICU at the hospital to see what staff and patients experience every day. (Source: CBC | Health)
MedWorm: Intensive Care
Mon Nov 11, 2019 10:00
Invasive pulmonary aspergillosis in patients admitted to the intensive care unit with severe influenza pneumonia: An observational study from a developing country
Conference abstracts (Source: The Aspergillus Website - updates)
MedWorm: Intensive Care
Mon Nov 11, 2019 00:08

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου